Clitazone (Clonixin Lysine Salt)

Adult dose

○ Adults: Administer 125∼250 mg of clonixin lysinate orally 3 times daily.

This medication should be discussed with a doctor or pharmacist if the person regularly consumes more than three glasses of alcohol per day, as it may increase the risk of gastrointestinal bleeding. This medication may affect the cardiovascular system, increasing the risk of serious thrombosis reactions such as myocardial infarction or stroke; thus, patients with cardiovascular diseases or risk factors should exercise caution. During the use of this medication, patients should closely monitor for any cardiovascular symptoms and consult medical professionals immediately if they occur. This medication can cause serious gastrointestinal adverse reactions such as bleeding, ulcers, or perforation; hence, elderly patients or those with a history of gastrointestinal diseases require extra caution. Long-term use of this medication may increase the risk of gastrointestinal adverse reactions, so if symptoms like gastrointestinal bleeding or abdominal pain occur while taking it, patients should consult medical professionals immediately. Patients with a history of peptic ulcers, hypersensitivity to this drug or its components, allergies to aspirin or other non-steroidal anti-inflammatory drugs, pregnant women or women who may become pregnant, and patients with severe liver, kidney, or heart diseases should not take this medication. The risk of adverse reactions may increase when this medication is used in combination with other non-steroidal anti-inflammatory drugs, ACE inhibitors, angiotensin II receptor antagonists, aspirin, diuretics, lithium, methotrexate, warfarin, cyclosporine, tacrolimus, antiplatelet agents, selective serotonin reuptake inhibitors (SSRIs), corticosteroids, etc., so caution is advised in combination. Patients with a history of peptic ulcers, hypertension, fluid retention, heart failure, liver impairment, kidney impairment, or bronchial asthma should consult medical professionals before taking this medication. It is recommended to discontinue breastfeeding or the administration of this medication, as it may be excreted in breast milk. If symptoms such as nausea, vomiting, diarrhea, abdominal pain, skin rash, anemia, liver function abnormalities, drowsiness, headache, etc., occur while taking this medication, it should be discontinued immediately, and patients should consult medical professionals. This medication should be administered at the minimum effective dose for the shortest duration possible, and regular blood tests with liver and kidney function tests are required for long-term use. This medication serves as symptomatic treatment to relieve inflammation and pain, and other treatments should be pursued if a causal treatment is necessary. Due to the increased risk of gastrointestinal bleeding, elderly or frail patients should be particularly cautious, and patients with hypertension should closely monitor their blood pressure. Patients with heart failure or edema may experience worsened fluid retention when taking this medication, so it should be used cautiously. Rarely, this medication may cause severe skin reactions and allergic responses such as anaphylaxis, so it should be discontinued immediately if symptoms like skin rash or difficulty breathing occur. This medication should be stored out of reach of children and should not be transferred to other containers.

Gastrointestinal bleeding, serious cardiovascular thrombotic reactions, myocardial infarction, stroke, bleeding from the stomach or intestines, ulcers, perforation, nausea, vomiting, diarrhea, constipation, abdominal pain, rash, itching, anemia, increased AST, increased ALT, drowsiness, headache, dizziness, cold sweats, chills, euphoric state, shock, jaundice, fulminant hepatitis, liver necrosis, liver failure, anemia, skin rash, exfoliative dermatitis, mucocutaneous syndrome, toxic epidermal necrolysis, bronchospasm, fluid retention, edema, renal papillary necrosis, kidney damage

This medication should be stored in a tightly sealed container to prevent air or moisture from entering. It is recommended to maintain the storage temperature between 1 and 30 degrees Celsius at room temperature. This will help preserve the medication's effectiveness for a longer time.

Appearance

Round film-coated tablet, whitish to pale yellow

Package unit

10 tablets/PTP